Alyeska Investment Group, L.P. 13D and 13G filings for Aligos Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 4:37 pm Sale |
2024-09-30 | 13G | Aligos Therapeutics, Inc. ALGS |
Alyeska Investment Group, L.P. | 146,472 4.800% |
-140,599 (-48.98%) |
Filing |
| 2024-02-14 1:53 pm Purchase |
2023-12-31 | 13G | Aligos Therapeutics, Inc. ALGS |
Alyeska Investment Group, L.P. | 287,071 9.990% |
287,071 (New Position) |
Filing |